Automated stenosis estimation of coronary angiographies using end-to-end learning
- PMID: 39789341
- PMCID: PMC11880145
- DOI: 10.1007/s10554-025-03324-x
Automated stenosis estimation of coronary angiographies using end-to-end learning
Abstract
The initial evaluation of stenosis during coronary angiography is typically performed by visual assessment. Visual assessment has limited accuracy compared to fractional flow reserve and quantitative coronary angiography, which are more time-consuming and costly. Applying deep learning might yield a faster and more accurate stenosis assessment. We developed a deep learning model to classify cine loops into left or right coronary artery (LCA/RCA) or "other". Data were obtained by manual annotation. Using these classifications, cine loops before revascularization were identified and curated automatically. Separate deep learning models for LCA and RCA were developed to estimate stenosis using these identified cine loops. From a cohort of 19,414 patients and 332,582 cine loops, we identified cine loops for 13,480 patients for model development and 5056 for internal testing. External testing was conducted using automated identified cine loops from 608 patients. For identification of significant stenosis (visual assessment of diameter stenosis > 70%), our model obtained a receiver operator characteristic (ROC) area under the curve (ROC-AUC) of 0.903 (95% CI: 0.900-0.906) on the internal test. The performance was evaluated on the external test set against visual assessment, 3D quantitative coronary angiography, and fractional flow reserve (≤ 0.80), obtaining ROC AUC values of 0.833 (95% CI: 0.814-0.852), 0.798 (95% CI: 0.741-0.842), and 0.780 (95% CI: 0.743-0.817), respectively. The deep-learning-based stenosis estimation models showed promising results for predicting stenosis. Compared to previous work, our approach demonstrates performance increase, includes all 16 segments, does not exclude revascularized patients, is externally tested, and is simpler using fewer steps.
Keywords: Coronary angiography; Coronary artery disease; Deep learning; Ischemic heart disease; Myocardial infarction; Quantitative coronary angiography.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: Søren Brunak has ownership in Intomics A/S, Hoba Therapeutics Aps, Novo Nordisk A/S, Lundbeck A/S, Eli Lilly & Co and ALK Abello and has managing board memberships in Proscion A/S and Intomics A/S. Morten Bøttcher declares advisory board work for Astra Zeneca, Novo Nordisk A/S, Sanofi, Bayer, Pfizer/BMS, Acarix, Boehringer Ingelheim and Novartis. The remaining authors declare no conflicts of interests. Ethical approval: Approval for data access was granted by the National Committee on Health Research Ethics (1708829 "Genetics of cardiovascular disease", ID P-2019-93), The Danish Data Protection Agency (ref: 514-0255/18-3000, 514-0254/18-3000, SUND-2016-50), and by the Danish Patient Safety Authority (3-3013-1731-1, appendix 31-1522-23). All personal identifiers were pseudo-anonymized.
Figures
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
